nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—CRABP1—kidney cancer	0.498	0.917	CbGaD
Alitretinoin—ABCB1—kidney cancer	0.045	0.0828	CbGaD
Alitretinoin—ABCB1—Temsirolimus—kidney cancer	0.0284	0.172	CbGbCtD
Alitretinoin—CYP1A2—Pazopanib—kidney cancer	0.017	0.103	CbGbCtD
Alitretinoin—ABCB1—Pazopanib—kidney cancer	0.0149	0.0903	CbGbCtD
Alitretinoin—ABCB1—Dactinomycin—kidney cancer	0.0136	0.0826	CbGbCtD
Alitretinoin—CYP1A2—Erlotinib—kidney cancer	0.0122	0.0737	CbGbCtD
Alitretinoin—ABCB1—Gemcitabine—kidney cancer	0.0108	0.0653	CbGbCtD
Alitretinoin—ABCB1—Erlotinib—kidney cancer	0.0106	0.0645	CbGbCtD
Alitretinoin—CYP1A2—Sorafenib—kidney cancer	0.00989	0.0599	CbGbCtD
Alitretinoin—ABCB1—Paclitaxel—kidney cancer	0.00974	0.059	CbGbCtD
Alitretinoin—ABCB1—Sorafenib—kidney cancer	0.00865	0.0524	CbGbCtD
Alitretinoin—ABCB1—Vinblastine—kidney cancer	0.00854	0.0517	CbGbCtD
Alitretinoin—ABCB1—Vincristine—kidney cancer	0.0084	0.0509	CbGbCtD
Alitretinoin—ABCB1—Sunitinib—kidney cancer	0.00701	0.0425	CbGbCtD
Alitretinoin—ABCB1—Doxorubicin—kidney cancer	0.00525	0.0318	CbGbCtD
Alitretinoin—Vitamin A—ALDH1A1—kidney cancer	0.00169	0.349	CrCbGaD
Alitretinoin—Tretinoin—ALDH1A1—kidney cancer	0.00163	0.337	CrCbGaD
Alitretinoin—CRABP1—cortex of kidney—kidney cancer	0.00132	0.109	CbGeAlD
Alitretinoin—CYP1A2—urine—kidney cancer	0.00132	0.109	CbGeAlD
Alitretinoin—RXRA—renal system—kidney cancer	0.00126	0.105	CbGeAlD
Alitretinoin—CRABP1—gonad—kidney cancer	0.00126	0.104	CbGeAlD
Alitretinoin—RXRA—kidney—kidney cancer	0.00122	0.101	CbGeAlD
Alitretinoin—CRABP2—gonad—kidney cancer	0.00114	0.0942	CbGeAlD
Alitretinoin—Tretinoin—CRABP1—kidney cancer	0.00113	0.233	CrCbGaD
Alitretinoin—RXRB—cardiac atrium—kidney cancer	0.000935	0.0773	CbGeAlD
Alitretinoin—RARA—renal system—kidney cancer	0.000871	0.0721	CbGeAlD
Alitretinoin—RARA—kidney—kidney cancer	0.000842	0.0697	CbGeAlD
Alitretinoin—RARA—gonad—kidney cancer	0.000781	0.0646	CbGeAlD
Alitretinoin—CYP1A2—renal system—kidney cancer	0.000323	0.0267	CbGeAlD
Alitretinoin—Vitamin A—CYP1A1—kidney cancer	0.000199	0.0411	CrCbGaD
Alitretinoin—Tretinoin—CYP1A1—kidney cancer	0.000192	0.0397	CrCbGaD
Alitretinoin—ABCB1—nephron tubule—kidney cancer	0.000182	0.0151	CbGeAlD
Alitretinoin—ABCB1—renal system—kidney cancer	0.000165	0.0137	CbGeAlD
Alitretinoin—ABCB1—kidney—kidney cancer	0.00016	0.0132	CbGeAlD
Alitretinoin—ABCB1—cortex of kidney—kidney cancer	0.000156	0.0129	CbGeAlD
Alitretinoin—ABCB1—gonad—kidney cancer	0.000148	0.0123	CbGeAlD
Alitretinoin—Nausea—Erlotinib—kidney cancer	3.64e-05	0.000205	CcSEcCtD
Alitretinoin—Alopecia—Capecitabine—kidney cancer	3.64e-05	0.000205	CcSEcCtD
Alitretinoin—Dry mouth—Paclitaxel—kidney cancer	3.64e-05	0.000205	CcSEcCtD
Alitretinoin—Mood swings—Doxorubicin—kidney cancer	3.64e-05	0.000204	CcSEcCtD
Alitretinoin—Diarrhoea—Sunitinib—kidney cancer	3.63e-05	0.000204	CcSEcCtD
Alitretinoin—Mental disorder—Capecitabine—kidney cancer	3.61e-05	0.000203	CcSEcCtD
Alitretinoin—Asthenia—Dactinomycin—kidney cancer	3.61e-05	0.000203	CcSEcCtD
Alitretinoin—Confusional state—Paclitaxel—kidney cancer	3.6e-05	0.000202	CcSEcCtD
Alitretinoin—Blood creatinine increased—Doxorubicin—kidney cancer	3.6e-05	0.000202	CcSEcCtD
Alitretinoin—Erythema—Capecitabine—kidney cancer	3.59e-05	0.000202	CcSEcCtD
Alitretinoin—Malnutrition—Capecitabine—kidney cancer	3.59e-05	0.000202	CcSEcCtD
Alitretinoin—Dehydration—Doxorubicin—kidney cancer	3.57e-05	0.000201	CcSEcCtD
Alitretinoin—Anaphylactic shock—Paclitaxel—kidney cancer	3.57e-05	0.000201	CcSEcCtD
Alitretinoin—Oedema—Paclitaxel—kidney cancer	3.57e-05	0.000201	CcSEcCtD
Alitretinoin—Abdominal pain—Vincristine—kidney cancer	3.55e-05	0.0002	CcSEcCtD
Alitretinoin—Body temperature increased—Vincristine—kidney cancer	3.55e-05	0.0002	CcSEcCtD
Alitretinoin—Infection—Paclitaxel—kidney cancer	3.54e-05	0.000199	CcSEcCtD
Alitretinoin—Flatulence—Capecitabine—kidney cancer	3.53e-05	0.000199	CcSEcCtD
Alitretinoin—Dry skin—Doxorubicin—kidney cancer	3.52e-05	0.000198	CcSEcCtD
Alitretinoin—Dizziness—Sunitinib—kidney cancer	3.51e-05	0.000197	CcSEcCtD
Alitretinoin—Feeling abnormal—Gemcitabine—kidney cancer	3.51e-05	0.000197	CcSEcCtD
Alitretinoin—Shock—Paclitaxel—kidney cancer	3.51e-05	0.000197	CcSEcCtD
Alitretinoin—Vomiting—Sorafenib—kidney cancer	3.51e-05	0.000197	CcSEcCtD
Alitretinoin—Nervous system disorder—Paclitaxel—kidney cancer	3.5e-05	0.000197	CcSEcCtD
Alitretinoin—Thrombocytopenia—Paclitaxel—kidney cancer	3.49e-05	0.000196	CcSEcCtD
Alitretinoin—Tachycardia—Paclitaxel—kidney cancer	3.48e-05	0.000196	CcSEcCtD
Alitretinoin—Rash—Sorafenib—kidney cancer	3.48e-05	0.000196	CcSEcCtD
Alitretinoin—Dermatitis—Sorafenib—kidney cancer	3.48e-05	0.000195	CcSEcCtD
Alitretinoin—Back pain—Capecitabine—kidney cancer	3.47e-05	0.000195	CcSEcCtD
Alitretinoin—Skin disorder—Paclitaxel—kidney cancer	3.47e-05	0.000195	CcSEcCtD
Alitretinoin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	3.46e-05	0.000194	CcSEcCtD
Alitretinoin—Headache—Sorafenib—kidney cancer	3.46e-05	0.000194	CcSEcCtD
Alitretinoin—Hyperhidrosis—Paclitaxel—kidney cancer	3.45e-05	0.000194	CcSEcCtD
Alitretinoin—Diarrhoea—Dactinomycin—kidney cancer	3.44e-05	0.000193	CcSEcCtD
Alitretinoin—Nasopharyngitis—Doxorubicin—kidney cancer	3.43e-05	0.000193	CcSEcCtD
Alitretinoin—Anorexia—Paclitaxel—kidney cancer	3.4e-05	0.000191	CcSEcCtD
Alitretinoin—Gastritis—Doxorubicin—kidney cancer	3.4e-05	0.000191	CcSEcCtD
Alitretinoin—Vision blurred—Capecitabine—kidney cancer	3.38e-05	0.00019	CcSEcCtD
Alitretinoin—Vomiting—Sunitinib—kidney cancer	3.38e-05	0.00019	CcSEcCtD
Alitretinoin—Body temperature increased—Gemcitabine—kidney cancer	3.37e-05	0.000189	CcSEcCtD
Alitretinoin—Tremor—Capecitabine—kidney cancer	3.36e-05	0.000189	CcSEcCtD
Alitretinoin—Rash—Sunitinib—kidney cancer	3.35e-05	0.000188	CcSEcCtD
Alitretinoin—Dermatitis—Sunitinib—kidney cancer	3.35e-05	0.000188	CcSEcCtD
Alitretinoin—Abdominal distension—Doxorubicin—kidney cancer	3.34e-05	0.000188	CcSEcCtD
Alitretinoin—Hypotension—Paclitaxel—kidney cancer	3.33e-05	0.000187	CcSEcCtD
Alitretinoin—Ill-defined disorder—Capecitabine—kidney cancer	3.33e-05	0.000187	CcSEcCtD
Alitretinoin—Headache—Sunitinib—kidney cancer	3.33e-05	0.000187	CcSEcCtD
Alitretinoin—Asthma—Doxorubicin—kidney cancer	3.32e-05	0.000187	CcSEcCtD
Alitretinoin—Dysphagia—Doxorubicin—kidney cancer	3.32e-05	0.000187	CcSEcCtD
Alitretinoin—Anaemia—Capecitabine—kidney cancer	3.32e-05	0.000186	CcSEcCtD
Alitretinoin—Hypersensitivity—Vincristine—kidney cancer	3.31e-05	0.000186	CcSEcCtD
Alitretinoin—Nausea—Sorafenib—kidney cancer	3.28e-05	0.000184	CcSEcCtD
Alitretinoin—Pancreatitis—Doxorubicin—kidney cancer	3.25e-05	0.000183	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	3.25e-05	0.000183	CcSEcCtD
Alitretinoin—Malaise—Capecitabine—kidney cancer	3.23e-05	0.000182	CcSEcCtD
Alitretinoin—Insomnia—Paclitaxel—kidney cancer	3.23e-05	0.000181	CcSEcCtD
Alitretinoin—Asthenia—Vincristine—kidney cancer	3.22e-05	0.000181	CcSEcCtD
Alitretinoin—Syncope—Capecitabine—kidney cancer	3.22e-05	0.000181	CcSEcCtD
Alitretinoin—Paraesthesia—Paclitaxel—kidney cancer	3.2e-05	0.00018	CcSEcCtD
Alitretinoin—Vomiting—Dactinomycin—kidney cancer	3.2e-05	0.00018	CcSEcCtD
Alitretinoin—Dyspnoea—Paclitaxel—kidney cancer	3.18e-05	0.000179	CcSEcCtD
Alitretinoin—Somnolence—Paclitaxel—kidney cancer	3.17e-05	0.000178	CcSEcCtD
Alitretinoin—Palpitations—Capecitabine—kidney cancer	3.17e-05	0.000178	CcSEcCtD
Alitretinoin—Rash—Dactinomycin—kidney cancer	3.17e-05	0.000178	CcSEcCtD
Alitretinoin—Nausea—Sunitinib—kidney cancer	3.15e-05	0.000177	CcSEcCtD
Alitretinoin—Loss of consciousness—Capecitabine—kidney cancer	3.15e-05	0.000177	CcSEcCtD
Alitretinoin—Dyspepsia—Paclitaxel—kidney cancer	3.14e-05	0.000177	CcSEcCtD
Alitretinoin—Cough—Capecitabine—kidney cancer	3.13e-05	0.000176	CcSEcCtD
Alitretinoin—Dysuria—Doxorubicin—kidney cancer	3.1e-05	0.000174	CcSEcCtD
Alitretinoin—Neutropenia—Doxorubicin—kidney cancer	3.1e-05	0.000174	CcSEcCtD
Alitretinoin—Decreased appetite—Paclitaxel—kidney cancer	3.1e-05	0.000174	CcSEcCtD
Alitretinoin—Hypertension—Capecitabine—kidney cancer	3.1e-05	0.000174	CcSEcCtD
Alitretinoin—Upper respiratory tract infection—Doxorubicin—kidney cancer	3.08e-05	0.000173	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Paclitaxel—kidney cancer	3.08e-05	0.000173	CcSEcCtD
Alitretinoin—Fatigue—Paclitaxel—kidney cancer	3.08e-05	0.000173	CcSEcCtD
Alitretinoin—Diarrhoea—Vincristine—kidney cancer	3.07e-05	0.000173	CcSEcCtD
Alitretinoin—Pollakiuria—Doxorubicin—kidney cancer	3.07e-05	0.000172	CcSEcCtD
Alitretinoin—Asthenia—Gemcitabine—kidney cancer	3.06e-05	0.000172	CcSEcCtD
Alitretinoin—Arthralgia—Capecitabine—kidney cancer	3.05e-05	0.000172	CcSEcCtD
Alitretinoin—Myalgia—Capecitabine—kidney cancer	3.05e-05	0.000172	CcSEcCtD
Alitretinoin—Chest pain—Capecitabine—kidney cancer	3.05e-05	0.000172	CcSEcCtD
Alitretinoin—Pain—Paclitaxel—kidney cancer	3.05e-05	0.000171	CcSEcCtD
Alitretinoin—Constipation—Paclitaxel—kidney cancer	3.05e-05	0.000171	CcSEcCtD
Alitretinoin—Anxiety—Capecitabine—kidney cancer	3.04e-05	0.000171	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	3.03e-05	0.00017	CcSEcCtD
Alitretinoin—Photosensitivity reaction—Doxorubicin—kidney cancer	3.03e-05	0.00017	CcSEcCtD
Alitretinoin—Weight increased—Doxorubicin—kidney cancer	3.02e-05	0.00017	CcSEcCtD
Alitretinoin—Discomfort—Capecitabine—kidney cancer	3.02e-05	0.00017	CcSEcCtD
Alitretinoin—Pruritus—Gemcitabine—kidney cancer	3.01e-05	0.000169	CcSEcCtD
Alitretinoin—Weight decreased—Doxorubicin—kidney cancer	3e-05	0.000169	CcSEcCtD
Alitretinoin—Dry mouth—Capecitabine—kidney cancer	2.99e-05	0.000168	CcSEcCtD
Alitretinoin—Nausea—Dactinomycin—kidney cancer	2.99e-05	0.000168	CcSEcCtD
Alitretinoin—Pneumonia—Doxorubicin—kidney cancer	2.98e-05	0.000167	CcSEcCtD
Alitretinoin—Dizziness—Vincristine—kidney cancer	2.97e-05	0.000167	CcSEcCtD
Alitretinoin—Infestation—Doxorubicin—kidney cancer	2.96e-05	0.000166	CcSEcCtD
Alitretinoin—Infestation NOS—Doxorubicin—kidney cancer	2.96e-05	0.000166	CcSEcCtD
Alitretinoin—Drowsiness—Doxorubicin—kidney cancer	2.96e-05	0.000166	CcSEcCtD
Alitretinoin—Confusional state—Capecitabine—kidney cancer	2.95e-05	0.000166	CcSEcCtD
Alitretinoin—Feeling abnormal—Paclitaxel—kidney cancer	2.94e-05	0.000165	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	2.93e-05	0.000165	CcSEcCtD
Alitretinoin—Oedema—Capecitabine—kidney cancer	2.93e-05	0.000165	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Paclitaxel—kidney cancer	2.92e-05	0.000164	CcSEcCtD
Alitretinoin—Diarrhoea—Gemcitabine—kidney cancer	2.92e-05	0.000164	CcSEcCtD
Alitretinoin—Renal failure—Doxorubicin—kidney cancer	2.91e-05	0.000163	CcSEcCtD
Alitretinoin—Infection—Capecitabine—kidney cancer	2.91e-05	0.000163	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Doxorubicin—kidney cancer	2.9e-05	0.000163	CcSEcCtD
Alitretinoin—Stomatitis—Doxorubicin—kidney cancer	2.88e-05	0.000162	CcSEcCtD
Alitretinoin—Shock—Capecitabine—kidney cancer	2.88e-05	0.000162	CcSEcCtD
Alitretinoin—Urinary tract infection—Doxorubicin—kidney cancer	2.88e-05	0.000162	CcSEcCtD
Alitretinoin—Conjunctivitis—Doxorubicin—kidney cancer	2.88e-05	0.000162	CcSEcCtD
Alitretinoin—Nervous system disorder—Capecitabine—kidney cancer	2.87e-05	0.000161	CcSEcCtD
Alitretinoin—Thrombocytopenia—Capecitabine—kidney cancer	2.87e-05	0.000161	CcSEcCtD
Alitretinoin—Tachycardia—Capecitabine—kidney cancer	2.86e-05	0.000161	CcSEcCtD
Alitretinoin—Vomiting—Vincristine—kidney cancer	2.86e-05	0.000161	CcSEcCtD
Alitretinoin—Skin disorder—Capecitabine—kidney cancer	2.84e-05	0.00016	CcSEcCtD
Alitretinoin—Sweating—Doxorubicin—kidney cancer	2.84e-05	0.000159	CcSEcCtD
Alitretinoin—Urticaria—Paclitaxel—kidney cancer	2.83e-05	0.000159	CcSEcCtD
Alitretinoin—Rash—Vincristine—kidney cancer	2.83e-05	0.000159	CcSEcCtD
Alitretinoin—Hyperhidrosis—Capecitabine—kidney cancer	2.83e-05	0.000159	CcSEcCtD
Alitretinoin—Dermatitis—Vincristine—kidney cancer	2.83e-05	0.000159	CcSEcCtD
Alitretinoin—Haematuria—Doxorubicin—kidney cancer	2.82e-05	0.000159	CcSEcCtD
Alitretinoin—Body temperature increased—Paclitaxel—kidney cancer	2.82e-05	0.000159	CcSEcCtD
Alitretinoin—Abdominal pain—Paclitaxel—kidney cancer	2.82e-05	0.000159	CcSEcCtD
Alitretinoin—Headache—Vincristine—kidney cancer	2.81e-05	0.000158	CcSEcCtD
Alitretinoin—Epistaxis—Doxorubicin—kidney cancer	2.79e-05	0.000157	CcSEcCtD
Alitretinoin—Anorexia—Capecitabine—kidney cancer	2.79e-05	0.000157	CcSEcCtD
Alitretinoin—Sinusitis—Doxorubicin—kidney cancer	2.78e-05	0.000156	CcSEcCtD
Alitretinoin—Agranulocytosis—Doxorubicin—kidney cancer	2.76e-05	0.000155	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—GSTM1—kidney cancer	2.75e-05	0.000284	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GSTM1—kidney cancer	2.75e-05	0.000284	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.75e-05	0.000284	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—TET2—kidney cancer	2.74e-05	0.000283	CbGpPWpGaD
Alitretinoin—Hypotension—Capecitabine—kidney cancer	2.74e-05	0.000154	CcSEcCtD
Alitretinoin—RXRA—Developmental Biology—PAK1—kidney cancer	2.71e-05	0.000279	CbGpPWpGaD
Alitretinoin—Vomiting—Gemcitabine—kidney cancer	2.71e-05	0.000152	CcSEcCtD
Alitretinoin—Rash—Gemcitabine—kidney cancer	2.69e-05	0.000151	CcSEcCtD
Alitretinoin—Dermatitis—Gemcitabine—kidney cancer	2.68e-05	0.000151	CcSEcCtD
Alitretinoin—Haemoglobin—Doxorubicin—kidney cancer	2.67e-05	0.00015	CcSEcCtD
Alitretinoin—Headache—Gemcitabine—kidney cancer	2.67e-05	0.00015	CcSEcCtD
Alitretinoin—Nausea—Vincristine—kidney cancer	2.67e-05	0.00015	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Capecitabine—kidney cancer	2.67e-05	0.00015	CcSEcCtD
Alitretinoin—RXRB—Gene Expression—JUNB—kidney cancer	2.66e-05	0.000274	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—JUNB—kidney cancer	2.66e-05	0.000274	CbGpPWpGaD
Alitretinoin—Hepatitis—Doxorubicin—kidney cancer	2.66e-05	0.000149	CcSEcCtD
Alitretinoin—Haemorrhage—Doxorubicin—kidney cancer	2.66e-05	0.000149	CcSEcCtD
Alitretinoin—CYP1A2—Phase II conjugation—GSTM1—kidney cancer	2.65e-05	0.000274	CbGpPWpGaD
Alitretinoin—Insomnia—Capecitabine—kidney cancer	2.65e-05	0.000149	CcSEcCtD
Alitretinoin—Hypoaesthesia—Doxorubicin—kidney cancer	2.64e-05	0.000149	CcSEcCtD
Alitretinoin—Pharyngitis—Doxorubicin—kidney cancer	2.64e-05	0.000148	CcSEcCtD
Alitretinoin—Paraesthesia—Capecitabine—kidney cancer	2.63e-05	0.000148	CcSEcCtD
Alitretinoin—Hypersensitivity—Paclitaxel—kidney cancer	2.63e-05	0.000148	CcSEcCtD
Alitretinoin—Urinary tract disorder—Doxorubicin—kidney cancer	2.62e-05	0.000147	CcSEcCtD
Alitretinoin—Oedema peripheral—Doxorubicin—kidney cancer	2.62e-05	0.000147	CcSEcCtD
Alitretinoin—RXRA—Metabolism—APRT—kidney cancer	2.61e-05	0.00027	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—FH—kidney cancer	2.61e-05	0.00027	CbGpPWpGaD
Alitretinoin—Dyspnoea—Capecitabine—kidney cancer	2.61e-05	0.000147	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.61e-05	0.000269	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CYP1A1—kidney cancer	2.61e-05	0.000269	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CYP1A1—kidney cancer	2.61e-05	0.000269	CbGpPWpGaD
Alitretinoin—Urethral disorder—Doxorubicin—kidney cancer	2.6e-05	0.000146	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	2.6e-05	0.000268	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	2.59e-05	0.000267	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	2.58e-05	0.000266	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.58e-05	0.000266	CbGpPWpGaD
Alitretinoin—Dyspepsia—Capecitabine—kidney cancer	2.58e-05	0.000145	CcSEcCtD
Alitretinoin—Visual impairment—Doxorubicin—kidney cancer	2.56e-05	0.000144	CcSEcCtD
Alitretinoin—Asthenia—Paclitaxel—kidney cancer	2.56e-05	0.000144	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.56e-05	0.000264	CbGpPWpGaD
Alitretinoin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.55e-05	0.000263	CbGpPWpGaD
Alitretinoin—Decreased appetite—Capecitabine—kidney cancer	2.55e-05	0.000143	CcSEcCtD
Alitretinoin—Nausea—Gemcitabine—kidney cancer	2.53e-05	0.000142	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Capecitabine—kidney cancer	2.53e-05	0.000142	CcSEcCtD
Alitretinoin—Fatigue—Capecitabine—kidney cancer	2.52e-05	0.000142	CcSEcCtD
Alitretinoin—Pruritus—Paclitaxel—kidney cancer	2.52e-05	0.000142	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.52e-05	0.00026	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—CDKN2B—kidney cancer	2.52e-05	0.00026	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	2.51e-05	0.000259	CbGpPWpGaD
Alitretinoin—Erythema multiforme—Doxorubicin—kidney cancer	2.51e-05	0.000141	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—TCEB1—kidney cancer	2.51e-05	0.000259	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—TCEB2—kidney cancer	2.51e-05	0.000259	CbGpPWpGaD
Alitretinoin—Constipation—Capecitabine—kidney cancer	2.5e-05	0.000141	CcSEcCtD
Alitretinoin—Pain—Capecitabine—kidney cancer	2.5e-05	0.000141	CcSEcCtD
Alitretinoin—Eye disorder—Doxorubicin—kidney cancer	2.48e-05	0.00014	CcSEcCtD
Alitretinoin—Tinnitus—Doxorubicin—kidney cancer	2.48e-05	0.000139	CcSEcCtD
Alitretinoin—Flushing—Doxorubicin—kidney cancer	2.47e-05	0.000139	CcSEcCtD
Alitretinoin—RXRA—Metabolism—GPC3—kidney cancer	2.46e-05	0.000254	CbGpPWpGaD
Alitretinoin—Diarrhoea—Paclitaxel—kidney cancer	2.44e-05	0.000137	CcSEcCtD
Alitretinoin—CYP1A2—Biological oxidations—GSTT1—kidney cancer	2.44e-05	0.000251	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Capecitabine—kidney cancer	2.41e-05	0.000136	CcSEcCtD
Alitretinoin—Angiopathy—Doxorubicin—kidney cancer	2.41e-05	0.000135	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.4e-05	0.000248	CbGpPWpGaD
Alitretinoin—Gastrointestinal pain—Capecitabine—kidney cancer	2.39e-05	0.000135	CcSEcCtD
Alitretinoin—RXRA—Metabolism—CA2—kidney cancer	2.39e-05	0.000247	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.39e-05	0.000246	CbGpPWpGaD
Alitretinoin—Chills—Doxorubicin—kidney cancer	2.38e-05	0.000134	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	2.38e-05	0.000246	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	2.38e-05	0.000246	CbGpPWpGaD
Alitretinoin—Arrhythmia—Doxorubicin—kidney cancer	2.37e-05	0.000133	CcSEcCtD
Alitretinoin—Dizziness—Paclitaxel—kidney cancer	2.36e-05	0.000133	CcSEcCtD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—PTGS2—kidney cancer	2.35e-05	0.000243	CbGpPWpGaD
Alitretinoin—Alopecia—Doxorubicin—kidney cancer	2.35e-05	0.000132	CcSEcCtD
Alitretinoin—RXRA—Generic Transcription Pathway—CDKN2B—kidney cancer	2.34e-05	0.000242	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALAD—kidney cancer	2.33e-05	0.00024	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	2.33e-05	0.00024	CbGpPWpGaD
Alitretinoin—Mental disorder—Doxorubicin—kidney cancer	2.33e-05	0.000131	CcSEcCtD
Alitretinoin—Urticaria—Capecitabine—kidney cancer	2.33e-05	0.000131	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.32e-05	0.000239	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	2.32e-05	0.000239	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	2.32e-05	0.000239	CbGpPWpGaD
Alitretinoin—Abdominal pain—Capecitabine—kidney cancer	2.31e-05	0.00013	CcSEcCtD
Alitretinoin—Body temperature increased—Capecitabine—kidney cancer	2.31e-05	0.00013	CcSEcCtD
Alitretinoin—Malnutrition—Doxorubicin—kidney cancer	2.31e-05	0.00013	CcSEcCtD
Alitretinoin—Erythema—Doxorubicin—kidney cancer	2.31e-05	0.00013	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—CDKN2B—kidney cancer	2.3e-05	0.000237	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—PTGS1—kidney cancer	2.28e-05	0.000236	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.28e-05	0.000235	CbGpPWpGaD
Alitretinoin—Flatulence—Doxorubicin—kidney cancer	2.28e-05	0.000128	CcSEcCtD
Alitretinoin—RXRA—Metabolism—ST3GAL2—kidney cancer	2.27e-05	0.000235	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.27e-05	0.000235	CbGpPWpGaD
Alitretinoin—Tension—Doxorubicin—kidney cancer	2.27e-05	0.000128	CcSEcCtD
Alitretinoin—Vomiting—Paclitaxel—kidney cancer	2.27e-05	0.000127	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	2.27e-05	0.000234	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—CDKN2B—kidney cancer	2.26e-05	0.000233	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.26e-05	0.000233	CbGpPWpGaD
Alitretinoin—Rash—Paclitaxel—kidney cancer	2.25e-05	0.000126	CcSEcCtD
Alitretinoin—Dermatitis—Paclitaxel—kidney cancer	2.25e-05	0.000126	CcSEcCtD
Alitretinoin—Nervousness—Doxorubicin—kidney cancer	2.25e-05	0.000126	CcSEcCtD
Alitretinoin—Back pain—Doxorubicin—kidney cancer	2.24e-05	0.000126	CcSEcCtD
Alitretinoin—Headache—Paclitaxel—kidney cancer	2.23e-05	0.000126	CcSEcCtD
Alitretinoin—RXRA—Metabolism—ALDH1A1—kidney cancer	2.22e-05	0.000229	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.2e-05	0.000227	CbGpPWpGaD
Alitretinoin—Vision blurred—Doxorubicin—kidney cancer	2.18e-05	0.000122	CcSEcCtD
Alitretinoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	2.17e-05	0.000224	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	2.17e-05	0.000223	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—CDKN2B—kidney cancer	2.16e-05	0.000223	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—CDKN2B—kidney cancer	2.16e-05	0.000223	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Capecitabine—kidney cancer	2.16e-05	0.000121	CcSEcCtD
Alitretinoin—Ill-defined disorder—Doxorubicin—kidney cancer	2.15e-05	0.000121	CcSEcCtD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.14e-05	0.000221	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.14e-05	0.000221	CbGpPWpGaD
Alitretinoin—Anaemia—Doxorubicin—kidney cancer	2.14e-05	0.00012	CcSEcCtD
Alitretinoin—RXRA—Metabolism—SLC5A3—kidney cancer	2.13e-05	0.00022	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PGK1—kidney cancer	2.13e-05	0.00022	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	2.13e-05	0.000219	CbGpPWpGaD
Alitretinoin—Agitation—Doxorubicin—kidney cancer	2.12e-05	0.000119	CcSEcCtD
Alitretinoin—Nausea—Paclitaxel—kidney cancer	2.12e-05	0.000119	CcSEcCtD
Alitretinoin—Asthenia—Capecitabine—kidney cancer	2.1e-05	0.000118	CcSEcCtD
Alitretinoin—RXRA—Metabolism—LDHB—kidney cancer	2.09e-05	0.000216	CbGpPWpGaD
Alitretinoin—Malaise—Doxorubicin—kidney cancer	2.09e-05	0.000117	CcSEcCtD
Alitretinoin—Syncope—Doxorubicin—kidney cancer	2.07e-05	0.000117	CcSEcCtD
Alitretinoin—Pruritus—Capecitabine—kidney cancer	2.07e-05	0.000116	CcSEcCtD
Alitretinoin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.07e-05	0.000213	CbGpPWpGaD
Alitretinoin—Palpitations—Doxorubicin—kidney cancer	2.04e-05	0.000115	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—RPL14—kidney cancer	2.04e-05	0.00021	CbGpPWpGaD
Alitretinoin—Loss of consciousness—Doxorubicin—kidney cancer	2.03e-05	0.000114	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—MYC—kidney cancer	2.03e-05	0.000209	CbGpPWpGaD
Alitretinoin—Cough—Doxorubicin—kidney cancer	2.02e-05	0.000113	CcSEcCtD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	2.01e-05	0.000208	CbGpPWpGaD
Alitretinoin—Convulsion—Doxorubicin—kidney cancer	2e-05	0.000113	CcSEcCtD
Alitretinoin—Diarrhoea—Capecitabine—kidney cancer	2e-05	0.000113	CcSEcCtD
Alitretinoin—Hypertension—Doxorubicin—kidney cancer	2e-05	0.000112	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.99e-05	0.000205	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	1.98e-05	0.000204	CbGpPWpGaD
Alitretinoin—Myalgia—Doxorubicin—kidney cancer	1.97e-05	0.000111	CcSEcCtD
Alitretinoin—Arthralgia—Doxorubicin—kidney cancer	1.97e-05	0.000111	CcSEcCtD
Alitretinoin—Chest pain—Doxorubicin—kidney cancer	1.97e-05	0.000111	CcSEcCtD
Alitretinoin—Anxiety—Doxorubicin—kidney cancer	1.96e-05	0.00011	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	1.96e-05	0.00011	CcSEcCtD
Alitretinoin—Discomfort—Doxorubicin—kidney cancer	1.95e-05	0.000109	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—POMC—kidney cancer	1.94e-05	0.0002	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—POMC—kidney cancer	1.94e-05	0.0002	CbGpPWpGaD
Alitretinoin—Dizziness—Capecitabine—kidney cancer	1.94e-05	0.000109	CcSEcCtD
Alitretinoin—Dry mouth—Doxorubicin—kidney cancer	1.93e-05	0.000108	CcSEcCtD
Alitretinoin—Confusional state—Doxorubicin—kidney cancer	1.9e-05	0.000107	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	1.9e-05	0.000196	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL2—kidney cancer	1.89e-05	0.000195	CbGpPWpGaD
Alitretinoin—Oedema—Doxorubicin—kidney cancer	1.89e-05	0.000106	CcSEcCtD
Alitretinoin—Anaphylactic shock—Doxorubicin—kidney cancer	1.89e-05	0.000106	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	1.89e-05	0.000194	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.88e-05	0.000194	CbGpPWpGaD
Alitretinoin—Infection—Doxorubicin—kidney cancer	1.87e-05	0.000105	CcSEcCtD
Alitretinoin—Vomiting—Capecitabine—kidney cancer	1.86e-05	0.000105	CcSEcCtD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	1.86e-05	0.000192	CbGpPWpGaD
Alitretinoin—Shock—Doxorubicin—kidney cancer	1.86e-05	0.000104	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—MYC—kidney cancer	1.85e-05	0.000191	CbGpPWpGaD
Alitretinoin—Nervous system disorder—Doxorubicin—kidney cancer	1.85e-05	0.000104	CcSEcCtD
Alitretinoin—Thrombocytopenia—Doxorubicin—kidney cancer	1.85e-05	0.000104	CcSEcCtD
Alitretinoin—Rash—Capecitabine—kidney cancer	1.85e-05	0.000104	CcSEcCtD
Alitretinoin—Dermatitis—Capecitabine—kidney cancer	1.84e-05	0.000104	CcSEcCtD
Alitretinoin—Tachycardia—Doxorubicin—kidney cancer	1.84e-05	0.000104	CcSEcCtD
Alitretinoin—Headache—Capecitabine—kidney cancer	1.83e-05	0.000103	CcSEcCtD
Alitretinoin—Skin disorder—Doxorubicin—kidney cancer	1.83e-05	0.000103	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.83e-05	0.000189	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.83e-05	0.000189	CbGpPWpGaD
Alitretinoin—Hyperhidrosis—Doxorubicin—kidney cancer	1.82e-05	0.000103	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	1.82e-05	0.000188	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	1.82e-05	0.000188	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	1.82e-05	0.000188	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	1.82e-05	0.000188	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—MYC—kidney cancer	1.82e-05	0.000187	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CA9—kidney cancer	1.81e-05	0.000187	CbGpPWpGaD
Alitretinoin—Anorexia—Doxorubicin—kidney cancer	1.8e-05	0.000101	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.79e-05	0.000184	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	1.78e-05	0.000184	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.77e-05	0.000183	CbGpPWpGaD
Alitretinoin—Hypotension—Doxorubicin—kidney cancer	1.76e-05	9.91e-05	CcSEcCtD
Alitretinoin—RARA—Generic Transcription Pathway—MYC—kidney cancer	1.74e-05	0.00018	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—MYC—kidney cancer	1.74e-05	0.00018	CbGpPWpGaD
Alitretinoin—Nausea—Capecitabine—kidney cancer	1.74e-05	9.77e-05	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.72e-05	9.66e-05	CcSEcCtD
Alitretinoin—Insomnia—Doxorubicin—kidney cancer	1.71e-05	9.59e-05	CcSEcCtD
Alitretinoin—Paraesthesia—Doxorubicin—kidney cancer	1.69e-05	9.52e-05	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.69e-05	0.000174	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—GSTP1—kidney cancer	1.69e-05	0.000174	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—KDR—kidney cancer	1.69e-05	0.000174	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	1.68e-05	0.000174	CbGpPWpGaD
Alitretinoin—Dyspnoea—Doxorubicin—kidney cancer	1.68e-05	9.46e-05	CcSEcCtD
Alitretinoin—Somnolence—Doxorubicin—kidney cancer	1.68e-05	9.43e-05	CcSEcCtD
Alitretinoin—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	1.67e-05	0.000172	CbGpPWpGaD
Alitretinoin—Dyspepsia—Doxorubicin—kidney cancer	1.66e-05	9.34e-05	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—EIF4EBP1—kidney cancer	1.66e-05	0.000171	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—HSPB1—kidney cancer	1.66e-05	0.000171	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MET—kidney cancer	1.65e-05	0.00017	CbGpPWpGaD
Alitretinoin—Decreased appetite—Doxorubicin—kidney cancer	1.64e-05	9.22e-05	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.63e-05	9.16e-05	CcSEcCtD
Alitretinoin—Fatigue—Doxorubicin—kidney cancer	1.63e-05	9.14e-05	CcSEcCtD
Alitretinoin—ABCB1—Metabolism—ACY1—kidney cancer	1.62e-05	0.000167	CbGpPWpGaD
Alitretinoin—Constipation—Doxorubicin—kidney cancer	1.61e-05	9.07e-05	CcSEcCtD
Alitretinoin—Pain—Doxorubicin—kidney cancer	1.61e-05	9.07e-05	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—VEGFA—kidney cancer	1.61e-05	0.000166	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Doxorubicin—kidney cancer	1.56e-05	8.74e-05	CcSEcCtD
Alitretinoin—CYP1A2—Biological oxidations—GSTM1—kidney cancer	1.55e-05	0.00016	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.55e-05	0.00016	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTGS2—kidney cancer	1.55e-05	0.00016	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTGS2—kidney cancer	1.55e-05	0.00016	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PSMD7—kidney cancer	1.54e-05	0.000159	CbGpPWpGaD
Alitretinoin—Gastrointestinal pain—Doxorubicin—kidney cancer	1.54e-05	8.67e-05	CcSEcCtD
Alitretinoin—RXRA—Metabolism—CRABP1—kidney cancer	1.54e-05	0.000159	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	1.53e-05	0.000158	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.5e-05	0.000155	CbGpPWpGaD
Alitretinoin—Urticaria—Doxorubicin—kidney cancer	1.5e-05	8.43e-05	CcSEcCtD
Alitretinoin—Abdominal pain—Doxorubicin—kidney cancer	1.49e-05	8.38e-05	CcSEcCtD
Alitretinoin—Body temperature increased—Doxorubicin—kidney cancer	1.49e-05	8.38e-05	CcSEcCtD
Alitretinoin—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	1.47e-05	0.000152	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	1.45e-05	0.00015	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ITPR2—kidney cancer	1.43e-05	0.000148	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Doxorubicin—kidney cancer	1.39e-05	7.81e-05	CcSEcCtD
Alitretinoin—RXRA—Gene Expression—JUNB—kidney cancer	1.39e-05	0.000143	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PDHB—kidney cancer	1.38e-05	0.000142	CbGpPWpGaD
Alitretinoin—Asthenia—Doxorubicin—kidney cancer	1.35e-05	7.61e-05	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—PTEN—kidney cancer	1.35e-05	0.000139	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTEN—kidney cancer	1.35e-05	0.000139	CbGpPWpGaD
Alitretinoin—Pruritus—Doxorubicin—kidney cancer	1.34e-05	7.5e-05	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	1.33e-05	0.000137	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.32e-05	0.000136	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTT1—kidney cancer	1.31e-05	0.000135	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ACHE—kidney cancer	1.31e-05	0.000135	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CCBL1—kidney cancer	1.3e-05	0.000134	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ACY1—kidney cancer	1.29e-05	0.000134	CbGpPWpGaD
Alitretinoin—Diarrhoea—Doxorubicin—kidney cancer	1.29e-05	7.26e-05	CcSEcCtD
Alitretinoin—Dizziness—Doxorubicin—kidney cancer	1.25e-05	7.01e-05	CcSEcCtD
Alitretinoin—RXRA—Metabolism—SCARB1—kidney cancer	1.24e-05	0.000128	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS1—kidney cancer	1.22e-05	0.000126	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—RAF1—kidney cancer	1.22e-05	0.000126	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—RELA—kidney cancer	1.21e-05	0.000125	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—ERBB2—kidney cancer	1.21e-05	0.000124	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PSMD7—kidney cancer	1.2e-05	0.000124	CbGpPWpGaD
Alitretinoin—Vomiting—Doxorubicin—kidney cancer	1.2e-05	6.74e-05	CcSEcCtD
Alitretinoin—Rash—Doxorubicin—kidney cancer	1.19e-05	6.69e-05	CcSEcCtD
Alitretinoin—Dermatitis—Doxorubicin—kidney cancer	1.19e-05	6.68e-05	CcSEcCtD
Alitretinoin—Headache—Doxorubicin—kidney cancer	1.18e-05	6.64e-05	CcSEcCtD
Alitretinoin—RXRA—Metabolism—BCHE—kidney cancer	1.14e-05	0.000117	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—CDKN2B—kidney cancer	1.13e-05	0.000116	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SLC5A5—kidney cancer	1.12e-05	0.000116	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GLIPR1—kidney cancer	1.12e-05	0.000116	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPAT—kidney cancer	1.12e-05	0.000116	CbGpPWpGaD
Alitretinoin—Nausea—Doxorubicin—kidney cancer	1.12e-05	6.3e-05	CcSEcCtD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.1e-05	0.000114	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PDHB—kidney cancer	1.1e-05	0.000114	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—POMC—kidney cancer	1.1e-05	0.000113	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SLC2A1—kidney cancer	1.09e-05	0.000112	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—CTNNB1—kidney cancer	1.06e-05	0.000109	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.05e-05	0.000109	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APRT—kidney cancer	1.04e-05	0.000108	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—FH—kidney cancer	1.04e-05	0.000108	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.04e-05	0.000107	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—RAF1—kidney cancer	1.04e-05	0.000107	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CCBL1—kidney cancer	1.03e-05	0.000107	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.03e-05	0.000106	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.01e-05	0.000104	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MAPK3—kidney cancer	1e-05	0.000103	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GPC3—kidney cancer	9.82e-06	0.000101	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MYC—kidney cancer	9.76e-06	0.000101	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	9.59e-06	9.89e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CA2—kidney cancer	9.56e-06	9.86e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	9.55e-06	9.85e-05	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CA—kidney cancer	9.53e-06	9.83e-05	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3CA—kidney cancer	9.53e-06	9.83e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	9.36e-06	9.65e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALAD—kidney cancer	9.31e-06	9.61e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VEGFA—kidney cancer	9.29e-06	9.58e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	9.26e-06	9.55e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.19e-06	9.48e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MAPK3—kidney cancer	9.17e-06	9.46e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	9.11e-06	9.39e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ST3GAL2—kidney cancer	9.09e-06	9.38e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	9.09e-06	9.38e-05	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—MYC—kidney cancer	9.08e-06	9.37e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTP1—kidney cancer	9.05e-06	9.34e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	9.02e-06	9.3e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MAPK3—kidney cancer	9e-06	9.28e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPAT—kidney cancer	8.97e-06	9.25e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GLIPR1—kidney cancer	8.97e-06	9.25e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MYC—kidney cancer	8.92e-06	9.2e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALDH1A1—kidney cancer	8.88e-06	9.16e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	8.86e-06	9.14e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	8.79e-06	9.07e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MAPK3—kidney cancer	8.79e-06	9.07e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	8.77e-06	9.04e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MYC—kidney cancer	8.75e-06	9.03e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MAPK3—kidney cancer	8.63e-06	8.9e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MAPK3—kidney cancer	8.63e-06	8.9e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ABCB1—kidney cancer	8.57e-06	8.84e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PGK1—kidney cancer	8.52e-06	8.79e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC5A3—kidney cancer	8.52e-06	8.79e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MYC—kidney cancer	8.39e-06	8.65e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MYC—kidney cancer	8.39e-06	8.65e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MAPK1—kidney cancer	8.36e-06	8.63e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LDHB—kidney cancer	8.35e-06	8.62e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APRT—kidney cancer	8.34e-06	8.6e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—FH—kidney cancer	8.34e-06	8.6e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTM1—kidney cancer	8.32e-06	8.58e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	8.15e-06	8.41e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	7.94e-06	8.19e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—KRAS—kidney cancer	7.9e-06	8.15e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP1A1—kidney cancer	7.89e-06	8.14e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GPC3—kidney cancer	7.84e-06	8.09e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CA2—kidney cancer	7.63e-06	7.87e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	7.51e-06	7.75e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALAD—kidney cancer	7.43e-06	7.67e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	7.31e-06	7.54e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ST3GAL2—kidney cancer	7.26e-06	7.48e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CA9—kidney cancer	7.24e-06	7.47e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	7.15e-06	7.37e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALDH1A1—kidney cancer	7.09e-06	7.32e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PGK1—kidney cancer	6.8e-06	7.01e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC5A3—kidney cancer	6.8e-06	7.01e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	6.75e-06	6.96e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LDHB—kidney cancer	6.67e-06	6.88e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.48e-06	6.68e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	6.2e-06	6.4e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CRABP1—kidney cancer	6.16e-06	6.35e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	6e-06	6.19e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—POMC—kidney cancer	5.88e-06	6.07e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CA9—kidney cancer	5.78e-06	5.96e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ITPR2—kidney cancer	5.72e-06	5.9e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.65e-06	5.83e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ACHE—kidney cancer	5.22e-06	5.38e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTT1—kidney cancer	5.22e-06	5.38e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SCARB1—kidney cancer	4.94e-06	5.1e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CRABP1—kidney cancer	4.92e-06	5.07e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS1—kidney cancer	4.89e-06	5.05e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PSMD7—kidney cancer	4.8e-06	4.95e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—kidney cancer	4.69e-06	4.84e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ITPR2—kidney cancer	4.57e-06	4.71e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—BCHE—kidney cancer	4.55e-06	4.69e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MAPK3—kidney cancer	4.5e-06	4.64e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC5A5—kidney cancer	4.49e-06	4.63e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MYC—kidney cancer	4.37e-06	4.51e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC2A1—kidney cancer	4.34e-06	4.48e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.21e-06	4.35e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTT1—kidney cancer	4.17e-06	4.3e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ACHE—kidney cancer	4.17e-06	4.3e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.14e-06	4.27e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTEN—kidney cancer	4.09e-06	4.22e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SCARB1—kidney cancer	3.94e-06	4.07e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS1—kidney cancer	3.91e-06	4.03e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PSMD7—kidney cancer	3.83e-06	3.95e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—BCHE—kidney cancer	3.63e-06	3.74e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTP1—kidney cancer	3.62e-06	3.73e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC5A5—kidney cancer	3.59e-06	3.7e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC2A1—kidney cancer	3.46e-06	3.57e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.36e-06	3.47e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTM1—kidney cancer	3.33e-06	3.43e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP1A1—kidney cancer	3.15e-06	3.25e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.93e-06	3.02e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTP1—kidney cancer	2.89e-06	2.98e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CA—kidney cancer	2.89e-06	2.98e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCB1—kidney cancer	2.73e-06	2.82e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTM1—kidney cancer	2.65e-06	2.74e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP1A1—kidney cancer	2.52e-06	2.6e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—POMC—kidney cancer	2.35e-06	2.42e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.07e-06	2.13e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—POMC—kidney cancer	1.88e-06	1.94e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—kidney cancer	1.87e-06	1.93e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTEN—kidney cancer	1.63e-06	1.69e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—kidney cancer	1.5e-06	1.54e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTEN—kidney cancer	1.31e-06	1.35e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CA—kidney cancer	1.15e-06	1.19e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CA—kidney cancer	9.21e-07	9.5e-06	CbGpPWpGaD
